NCT05137301

Brief Summary

High accuracy and precision bone age assessment is very important for the diagnosis and treatment monitoring of various pediatric diseases. The commonly used bone age assessment methods include GP atlas, TW3 score and Zhonghua 05. GP method is to compare wrist X-ray films with atlas reference X-ray films. Its main disadvantages are strong subjectivity and long atlas standard interval. Different from GP method, TW3 method is to grade and score each bone, add each epiphyseal score to calculate the total score of bone maturity, and obtain the corresponding final bone age value. Although TW3 scoring method is relatively accurate, it is complex and time-consuming, and there is great variability among evaluators. In order to evaluate bone age more efficiently and accurately, a method based on computer image automatic recognition technology can help to overcome these problems. In this study, 1000 children aged 1-18 in 5 hospitals are selected as the research objects. After taking bone age films with bone age instrument, the film reading results and evaluation time of AI Group, artificial group and standard group are recorded. One month later, the artificial group re-analyzes 1000 films with the assistance of AI system, and the evaluation time is recorded. Finally, the accuracy and time difference of artificial group, AI Group, artificial combined AI Group and standard group are compared. The purpose of this study is to use the most advanced artificial intelligence deep learning bone age evaluation software to explore the value of bone age instrument to improve the accuracy and diagnostic efficiency of bone age evaluation by pediatricians.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 11, 2021

Completed
19 days until next milestone

First Posted

Study publicly available on registry

November 30, 2021

Completed
3 months until next milestone

Study Start

First participant enrolled

February 21, 2022

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

April 20, 2023

Status Verified

April 1, 2023

Enrollment Period

2.9 years

First QC Date

November 11, 2021

Last Update Submit

April 18, 2023

Conditions

Keywords

bone age; TW3; AI

Outcome Measures

Primary Outcomes (1)

  • bone age

    The mean absolute error (MAE) and root mean square error (RSME) between the evaluation bone age results of different groups

    one month

Interventions

Bone age films were taken by X-ray bone age instrument

Eligibility Criteria

Age1 Year - 18 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodProbability Sample
Study Population

Children aged 1-18 who need bone age assessment

You may qualify if:

  • Children aged 1 to 18 years.
  • Clinical diagnosis of requiring bone age examination.

You may not qualify if:

  • There are obstructions or implants in the wrist bone, such as metal.
  • Poor resolution, which affects the observation of bone characteristics.
  • Poor shooting position of the wrist due to various reasons.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tongji Hospital Tongji Medical College of Hust

Wuhan, Hubei, China

RECRUITING

MeSH Terms

Conditions

Endocrine System Diseases

Study Officials

  • xiumin wang, director

    Shanghai Children's Medical Center

    PRINCIPAL INVESTIGATOR
  • xinran cheng, director

    Chendu Women's and children's central hospital

    PRINCIPAL INVESTIGATOR
  • xiaobo chen, director

    Children's Hospital of The Capital Institute of Pediatrics

    PRINCIPAL INVESTIGATOR
  • ZE SU, director

    Shenzhen Children's Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Xiaoping Luo, director

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Target Duration
1 Month
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of Pediatrics

Study Record Dates

First Submitted

November 11, 2021

First Posted

November 30, 2021

Study Start

February 21, 2022

Primary Completion

December 31, 2024

Study Completion

December 31, 2024

Last Updated

April 20, 2023

Record last verified: 2023-04

Data Sharing

IPD Sharing
Will not share

Locations